To our knowledge, this is the first experimental evidence showing that the expression of EGFRvIII, through SK1 activation and the increased extracellular S1P levels via the S1P1 receptor, favours the survival of human GBM cells. The gene discussed is SPHK1; the disease is glioblastoma.